These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 27958338)

  • 1. Ester-Modified Cyclometalated Iridium(III) Complexes as Mitochondria-Targeting Anticancer Agents.
    Wang FX; Chen MH; Hu XY; Ye RR; Tan CP; Ji LN; Mao ZW
    Sci Rep; 2016 Dec; 6():38954. PubMed ID: 27958338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valproic Acid-Functionalized Cyclometalated Iridium(III) Complexes as Mitochondria-Targeting Anticancer Agents.
    Ye RR; Cao JJ; Tan CP; Ji LN; Mao ZW
    Chemistry; 2017 Oct; 23(60):15166-15176. PubMed ID: 28833658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclometalated iridium(III) complexes as mitochondria-targeted anticancer agents.
    Xiong K; Chen Y; Ouyang C; Guan RL; Ji LN; Chao H
    Biochimie; 2016 Jun; 125():186-94. PubMed ID: 27039888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondria-targeted phosphorescent cyclometalated iridium(III) complexes: synthesis, characterization, and anticancer properties.
    Li Y; Liu B; Xu CX; He L; Wan YC; Ji LN; Mao ZW
    J Biol Inorg Chem; 2020 Jun; 25(4):597-607. PubMed ID: 32232583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclometalated iridium(iii) complexes induce mitochondria-derived paraptotic cell death and inhibit tumor growth in vivo.
    He L; Wang KN; Zheng Y; Cao JJ; Zhang MF; Tan CP; Ji LN; Mao ZW
    Dalton Trans; 2018 May; 47(20):6942-6953. PubMed ID: 29721561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iminoamido chelated iridium(III) and ruthenium(II) anticancer complexes with mitochondria-targeting ability and potential to overcome cisplatin resistance.
    Guo L; Li P; Jing Z; Gong Y; Lai K; Fu H; Dong H; Yang Z; Liu Z
    J Inorg Biochem; 2024 Sep; 258():112631. PubMed ID: 38843774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorinated cyclometalated iridium(iii) complexes as mitochondria-targeted theranostic anticancer agents.
    Ouyang M; Zeng L; Huang H; Jin C; Liu J; Chen Y; Ji L; Chao H
    Dalton Trans; 2017 May; 46(20):6734-6744. PubMed ID: 28488721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coumarin-appended phosphorescent cyclometalated iridium(iii) complexes as mitochondria-targeted theranostic anticancer agents.
    Ye RR; Tan CP; Ji LN; Mao ZW
    Dalton Trans; 2016 Aug; 45(33):13042-51. PubMed ID: 27139504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photoinduced anticancer activity studies of iridium(III) complexes targeting mitochondria and tubules.
    Zhang WY; Yi QY; Wang YJ; Du F; He M; Tang B; Wan D; Liu YJ; Huang HL
    Eur J Med Chem; 2018 May; 151():568-584. PubMed ID: 29656200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel and Versatile Imine-N-Heterocyclic Carbene Half-Sandwich Iridium(III) Complexes as Lysosome-Targeted Anticancer Agents.
    Yang Y; Guo L; Tian Z; Gong Y; Zheng H; Zhang S; Xu Z; Ge X; Liu Z
    Inorg Chem; 2018 Sep; 57(17):11087-11098. PubMed ID: 30133276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serendipitous Synthesis of Five-Coordinated Half-Sandwich Aminoimine Iridium(III) and Ruthenium(II) Complexes and Their Application as Potent Anticancer Agents.
    Du Q; Guo L; Ge X; Zhao L; Tian Z; Liu X; Zhang F; Liu Z
    Inorg Chem; 2019 May; 58(9):5956-5965. PubMed ID: 30986046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organometallic Iridium(III) anticancer complexes with new mechanisms of action: NCI-60 screening, mitochondrial targeting, and apoptosis.
    Hearn JM; Romero-Canelón I; Qamar B; Liu Z; Hands-Portman I; Sadler PJ
    ACS Chem Biol; 2013; 8(6):1335-43. PubMed ID: 23618382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclometalated iridium(III)-guanidinium complexes as mitochondria-targeted anticancer agents.
    Song XD; Kong X; He SF; Chen JX; Sun J; Chen BB; Zhao JW; Mao ZW
    Eur J Med Chem; 2017 Sep; 138():246-254. PubMed ID: 28668477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomes encapsulated iridium(III) polypyridyl complexes enhance anticancer activity in vitro and in vivo.
    Bai L; Fei WD; Gu YY; He M; Du F; Zhang WY; Yang LL; Liu YJ
    J Inorg Biochem; 2020 Apr; 205():111014. PubMed ID: 32044395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondria-targeting cyclometalated iridium(III)-PEG complexes with tunable photodynamic activity.
    Li SP; Lau CT; Louie MW; Lam YW; Cheng SH; Lo KK
    Biomaterials; 2013 Oct; 34(30):7519-32. PubMed ID: 23849346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclometalated iridium(III) complexes as mitochondria-targeted anticancer and antibacterial agents to induce both autophagy and apoptosis.
    Chen BB; Pan NL; Liao JX; Huang MY; Jiang DC; Wang JJ; Qiu HJ; Chen JX; Li L; Sun J
    J Inorg Biochem; 2021 Jun; 219():111450. PubMed ID: 33826973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features.
    Li J; Tian M; Tian Z; Zhang S; Yan C; Shao C; Liu Z
    Inorg Chem; 2018 Feb; 57(4):1705-1716. PubMed ID: 29400963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorescent iridium(III)-bis-N-heterocyclic carbene complexes as mitochondria-targeted theranostic and photodynamic anticancer agents.
    Li Y; Tan CP; Zhang W; He L; Ji LN; Mao ZW
    Biomaterials; 2015 Jan; 39():95-104. PubMed ID: 25477176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, photophysical and anticancer properties of mitochondria-targeted phosphorescent cyclometalated iridium(III) N-heterocyclic carbene complexes.
    Li Y; Wang KN; He L; Ji LN; Mao ZW
    J Inorg Biochem; 2020 Apr; 205():110976. PubMed ID: 31926377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential anticancer agent for selective damage to mitochondria or lysosomes: Naphthalimide-modified fluorescent biomarker half-sandwich iridium (III) and ruthenium (II) complexes.
    Ma W; Zhang S; Tian Z; Xu Z; Zhang Y; Xia X; Chen X; Liu Z
    Eur J Med Chem; 2019 Nov; 181():111599. PubMed ID: 31408807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.